Immuno-epigenetics study of the humoral immune response in COVID-19 patients from India
Implementing Organization
National Institute of Immunology (NII)
Principal Investigator
Dr. Nimesh Gupta
Scientist
|
National Institute of Immunology (NII)
About
The study aims to determine the characteristics of immune response to SARS-CoV-2 virus with key objectives of (1) defining the clinical spectrum in COVID-19 (2) detailed analysis of humoral responses to SARS-CoV-2 in terms of antibody repertoire, stability of memory B cells and traits of follicular T helper cells, as the key determinant of humoral immunity; and (3) the epigenetic signature of key adaptive immunity component in COVID-19
Disclaimer:
Information available on this portal is sourced from various organizations and is provided for informational purposes only. Users are advised to verify details from the respective official sources.
Please enter your details
Please provide your name and email to continue. Your details are saved in this browser for future use.
Latest Updates
Loading…
⚠️
You are leaving this website
You are about to be redirected to an external website that is not operated by
India Science, Technology & Innovation (ISTI) Portal.